The new grant issued

The new grant STRATEGMED TARGETTELO in the amount of 19 654 385.00 PLN issued by the National Center for Research and Development was begun by the academic-industrial consortium, composed of University of Gdańsk, Gdansk University of Technology, Medical University of Gdańsk, Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Nencki Institute of Experimental Biology Polish Academy of Sciences, The Provincial Hospitals in Gdynia Ltd., EU-CONSULT Sp. z o.o. and Innovabion Sp. z o.o. BioVentures Institute Sp. z o. o.scientists continuing their close cooperation with the University of Gdansk will develop key components of the proposed technology aiming at designing and constructing new anticancer compounds.

Patent application to USA, EU, Israel, Japan, China, India

BioVentures Institute Sp. z o.o. has extended the international PCT patent application no WO 2015162560 A1, covering the technology of construction of artificial, poly-epitopic proteins to the following countries: USA, EU, Israel, Japan, China, India.

Business relationship with Israeli companies

BioVentures Institute established business relationships with several Israeli companies, as well as with the Israeli Ministry of Regional Cooperation, Mr. MK Ayoob Kara, during technological presentation at Knesset, Israel.